Results 91 to 100 of about 1,890 (188)

Supplementary Material for: Rapid and effective elimination of myoglobin with CytoSorb® hemoadsorber in patients with severe rhabdomyolysis

, 2023
Introduction: Rhabdomyolysis is characterized by destruction of muscle fibres by various causes, diagnosed by increased creatin kinase concentrations in the blood. Myoglobin released into the blood may cause acute kidney injury.
Fuchs M. (17290282), Fliser D. (4161820), Albrecht F. (17290276), Schunk S. (17290279), Meiser A. (17290291), Geisel J. (17290288), Volk T. (17290285)   +6 more
core   +1 more source

Improved survival beyond 28 days up to 1 year after cytosorb treatment for refractory septic shock: A propensity-weighted retrospective survival analysis [PDF]

, 2020
Background and Aims: It is currently unknown whether CytoSorb treatment for septic shock improves long-term survival beyond 28 days from intensive care unit (ICU) admission and which factors determine outcome.
Brouwer, W.P. (Willem), Duran, Servet, Ince, C. (Can), Brouwer, Willem P.; id_orcid, Ince, Can, Duran, S. (Servet), Can Ince, Willem P. Brouwer, Servet Duran   +8 more
core   +1 more source

Severe Vasoplegic Syndrome Treated with Angiotensin II and Hemoadsorption Therapy after Cardiac Surgery

Catheterization and Cardiovascular Interventions, Volume 106, Issue 3, Page 1740-1745, September 1, 2025.
ABSTRACT Vasoplegic syndrome (VS) is a common complication after cardiac surgery with cardiopulmonary bypass (CPB). The main pathophysiology mechanism of VS includes a systemic inflammatory response syndrome due to surgical trauma, release of pro‐inflammatory mediators caused by blood contact with foreign surfaces of heart‐lung machine (pump and tubing)
Matteo Lucchelli, Davide Tommaso Andreis, Mattia Gomarasca, Giovanni Mistraletti   +3 more
wiley   +1 more source

Additional file 1 of Extracorporeal adsorption of protective and toxic bile acids and bilirubin in patients with cholestatic liver dysfunction: a prospective study

, 2023
Additional file 1. Table S1a: Total bilirubin concentration (mg/dL) pre- and post-Cytosorb® at different timepoints. Table S1b: Conjugated bilirubin concentration (mg/dL) pre- and post-Cytosorb® at different timepoints.
Katharina Habler (1409287), Clara Isabell Brozat (17369240), Uwe Liebchen (9677184), Michael Paal (3024075), Antonia Greimel (17369231), Michael Zoller (4530031), Christina Scharf (4530028), Nils Maciuga (17369237), Michael Vogeser (364534), Caroline Gräfe (17369234), Felix L. Happich (17369243), Sandra Frank (10029431)   +11 more
core   +1 more source

Effects of empagliflozin on uric acid levels during acute heart failure recompensation: A sub‐analysis of the EMPAG‐HF trial (Effects of Empagliflozin on Diuresis and Renal Function in Patients with Acute Decompensated Heart Failure)

European Journal of Heart Failure, Volume 27, Issue 8, Page 1472-1478, August 2025.
Effects of empagliflozin on uric acid levels during acute heart failure recompensation. Abstract Background Sodium–glucose cotransporter 2 inhibitors improve prognosis in chronic heart failure as part of currently recommended therapeutic strategies.
Jurgen Bogoviku, Tien Dung Nguyen, Julian Georg Westphal, Franz Haertel, Pawel Aftanski, Sven Möbius‐Winkler, Martin Busch, P. Christian Schulze   +7 more
wiley   +1 more source

Successful Reduction of Creatine Kinase and Myoglobin Levels in Severe Rhabdomyolysis Using Extracorporeal Blood Purification (CytoSorb®) [PDF]

, 2020
Rhabdomyolysis, if severe, can lead to acute kidney injury (AKI). Myoglobin is an iron and oxygen-binding protein that is freely filtered by the glomerulus.
Ince, C. (Can), Ormskerk, P. (Patricia), Thijsse, Sjoerd, Dilken, O. (Olcay), van der Hoven, Ben; id_orcid, van der Hoven, Ben, de Geus, Hilde, Hoven, B. (Ben) van der, Dilken, Olcay, Ormskerk, Patricia, Thijsse, S. (Sjoerd), Ince, Can, Geus, H.R.H. (Hilde) de, De Geus, Hilde R.H.   +13 more
core   +1 more source

Current and novel biomarkers in cardiogenic shock

European Journal of Heart Failure, Volume 27, Issue 6, Page 1106-1125, June 2025.
A summary of current and novel biomarkers and their potential stages of release in cardiogenic shock. The diagram illustrates the proposed release of the biomarkers during the different stages of cardiogenic shock: progression from cardiac dysfunction/stress, through to inflammation and end‐organ dysfunction.
Victor Galusko, Florian A. Wenzl, Christophe Vandenbriele, Vasileios Panoulas, Thomas F. Lüscher, Diana A. Gorog   +5 more
wiley   +1 more source

Hemoperfusion Combined With Continuous Renal Replacement Therapy in the Management of ARDS COVID‐19 Patients: A Quasi‐Experimental Study

Health Science Reports, Volume 8, Issue 4, April 2025.
ABSTRACT Background and Aims Critically ill patients in COVID‐19 to the intensive care unit (ICU) may develop multiple organ dysfunction syndrome, with some requiring extracorporeal organ support. This study aimed to assess the effects of combined CytoSorb hemoperfusion (HP) and continuous renal replacement therapy (CRRT) on the improvement of the ...
Seyed MohammadReza Hashemian, Ameneh Jafari, Batoul Khoundabi, Hamidreza Jamaati, Payam Rahimi   +4 more
wiley   +1 more source

Experience with hemoadsorption (CytoSorb ^® ) in the management of septic shock patients

World Journal of Critical Care Medicine, 2020
Cytokines and inflammatory mediators are the hallmarks of sepsis. Extracorporeal cytokine hemoadsorption devices are the newer clinical support system to overcome the cytokine storm during sepsis.To retrospectively evaluate the clinical outcomes of patients admitted in intensive care unit with septic shock with different etiologies.The laboratory ...
Mehta, Yatin, Mehta, Chitra, Kumar, Ashish, George, Joby Varghese, Gupta, Aditi, Nanda, Saurabh, Kochhar, Gourav, Raizada, Arun   +7 more
openaire   +2 more sources

Simultaneous Treatment of Two Severe Acute Intoxication and Acute Kidney Injury

Seminars in Dialysis, Volume 38, Issue 2, Page 152-155, March/April 2025.
ABSTRACT Extracorporeal therapies could be required for treatment of life‐threatening severe acute intoxication. We present the case of an 82‐year‐old patient admitted to our Nephrology Unit because of metformin‐associated lactic acidosis (MALA) and acute kidney injury (AKI stage III AKIN criteria).
Fulvia Zappulo, Laura Martano, Ines Ullo, Veronica Catalano, Sara Donini, Anna Scrivo, Anna Laura Croci Chiocchini, Gaetano La Manna   +7 more
wiley   +1 more source